InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,868.40
(
-0.79%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.01
(
-0.25%
)
Bitcoin
64,464.00
(
0.28%
)
Post# of 1466
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

railroadman

Send PM Follow Ignore
Followers 3
Posts 283
Boards Moderated 0
Alias Born 06/06/2014

railroadman

Re: 80857 post# 1414

Saturday, 03/11/2017 8:09:04 AM

Saturday, March 11, 2017 8:09:04 AM

Post# of 1466
New team cleaning up prior teams errors. Strengthen board, reduced costs and focus on higher margin products. They still have many hurdles to over come but they renewed focus and still have three committed large pharma's under contract. Financials still of oncern, but OrbiMed and Amgen ontrolling direction.

Watching Sanofi drug approvals this month. Maybe in a Unilife device.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up